Skip to main content

Table 1 Patient and disease charateristics

From: Prospective assessment of the quality of life before, during and after image guided intensity modulated radiotherapy for prostate cancer

Categorical characteristic No. patients n = 87 Percent
 T-stage
  ≤ T2a 17 19
  T2b 5 6
  ≥ T2c 65 75
 Gleason Score
  6 12 14
  7 49 56
  ≥ 8 26 30
 Risk group
  Low 0 0
  Intermediate 14 16
  High 73 84
 Type of ADT
  GnRH agonist 86 99
  Antiandrogen 1 1
Continuous characteristic Median Range
 PSA (ng/ml) 11 3.1–91.0
 Age (yr) 67 50–75